Glycated albumin suppresses glucose-induced insulin secretion by impairing glucose metabolism in rat pancreatic β-cells

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Shiraki, Takayuki ^a   Miura, Yoshikazu ^a   Sawada, Tokihiko ^a   Okada, Toshie ^a   Sakuraoka, Yuhki ^a   Muto, Takashi ^a   Kubota, Keiichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; COLLAGENASE; DIHYDROXYACETONE; FORSKOLIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCERALDEHYDE; GLYCOSYLATED ALBUMIN; HUMAN ALBUMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; POTASSIUM; PYRUVIC ACID; TOLBUTAMIDE;

AMADORI REARRANGEMENT; ANIMAL CELL; ARTICLE; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

RATTUS; RATTUS NORVEGICUS;

EID: 79953652749     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-20     Document Type: Article

References (38)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin dependent diabetes mellitus. The DCCT Research Group, New Eng J Med 1993 329 977 986 10.1056/ NEJM199309303291401 8366922
2. The glycosylation of hemoglobin: relevance to diabetes mellitus. HF Bunn KH Gabby PM Gallop, Science 1978 200 21 27 10.1126/science.635569 635569 (Pubitemid 8302924)
3. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. MP Cohen FN Ziyadeh, Kidney Int 1994 45 475 484 10.1038/ki.1994.62 8164436 (Pubitemid 24065083)
4. Diabetes and advanced glycation end products. H Vlassara MR Palace, J Intern Med 2002 251 87 101 10.1046/j.1365-2796.2002.00932.x 11905595 (Pubitemid 34146691)
5. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. S Yamagishi M Takeuchi Y Inagaki K Nakamura T Imaizumi, Int J Clin Pharmacol Res 2003 23 129 134 15224502 (Pubitemid 38821763)
6. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's Disease. M Takeuchi S Yamagishi, J Alzheimer Dis 2009 16 845 858
7. In skeletal muscle advanced glycation end-products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. A Cassese I Esposito F Fiory AP Barbagallo F Paturzo P Mirra L Ulianich F Giacco C Ladicicco A Lombardi F Oriente E Van Obberghen F Beguinot P Formisano C Miele, J Biol Chem 2008 52 36088 36099 10.1074/jbc.M801698200
8. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Y Hattori M Suzuki S Hattori K Kasai, Hypertension 2002 39 22 28 10.1161/hy1201.097300 11799073 (Pubitemid 34098083)
9. Glycated albumin stimulates gene expression in glomerular mesangial cells: involvement of the transforming growth factor- system. F Ziyadeh DC Han JA Cohen J Guo MP Cohen, Kidney Int 1998 53 631 638 10.1046/j.1523-1755.1998. 00815.x 9507208 (Pubitemid 28124277)
10. The biology of the receptor for advanced glycation end products and its ligands. AM Schmidt SD Yan SF Yan DM Stern, Biochim Biophys Acta 2000 1498 99 111 10.1016/S0167-4889(00)00087-2 11108954
11. Biochemistry and molecular cell biology of diabetic complications. M Brownlee, Nature 2001 414 813 820 10.1038/414813a 11742414 (Pubitemid 34000785)
12. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Z Zhao C Zhao XH Zhang F Zheng W Cai H Vlassara ZA Ma, Endocrinology 2009 150 2569 2576 10.1210/en.2008-1342 19246537
13. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. S Yamagishi M Takeuchi Y Inagaki K Nakamura T Imaizumi, Int J Clin Pharmacol Res 2003 23 129 134 15224502 (Pubitemid 38821763)
14. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. AM Schmidt SD Yan SF Yan DM Stern, J Clin Invest 2001 108 959 955
15. 2+ responses to glucose in pancreatic -cells. M Koizumi T Yada, J Endocrinol 2008 197 221 229 10.1677/JOE-07-0462 18434352 (Pubitemid 351696235)
16. Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. T Okeda J Ono R Takaki S Todo, Endocrinol Jpn 1979 26 495 499 387387 (Pubitemid 10196972)
17. From Nonenzymatic glucosylation of lysine residues in albumin. JW Baynes SR Thorpe MH Murtiashaw, Methods in Enzymology Orland: Academic Press, Finn Wold, Kivie Moldave, 1984 88 99 6436646
18. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C-mediated mechanism. C Miele A Riboulet MA Maitan F Oriente C Romano P Formisano J Giudicelli F Beguinot E Van Obberghen, J Biol Chem 2003 278 47376 47387 10.1074/jbc.M301088200 12970360 (Pubitemid 37523177)
19. Immunoassay of insulin. Two-antibody system, plasma insulin level of normal, subdiabetic, and diabetic rats. CR Morgen A Lazarow, Diabetes 1963 12 115 126
20. Activation of muscarinic receptors increases the concentration of free Na+ in mouse pancreatic cells. P Gilon JC Henquin, FEBS Lett 1993 315 353 356 10.1016/0014-5793(93)81193-4 8380774 (Pubitemid 23025038)
21. iassociated with insulin secretion in pancreatic -cells. Y Miura H Matsui, Am J Physiol Endocrinol Metab 2003 285 1001 E1009 14534075
22. 2+ indicators with greatly improved fluorescence properties. G Grynkiewiez M Poenie RY Tsien, J Biol Chem 1985 260 3440 3450 3838314 (Pubitemid 15114340)
23. Increased cytosolic calcium: a signal for sulfonylurea-stimulated insulin release from cells. TY Nelson KI Gaines AS Rajan M Berg AE Boyd III, J Biol Chem 1987 262 2608 2612 3029089
24. Deferoxamine enhances anti-proliferative effect of interferon- against hepatocellular carcinoma cells. T Okada T Sawada K Kubota, Cancer Lett 2007 248 24 31 10.1016/j.canlet.2006.05.014 16837131
25. The sulfonylurea receptor. AM Ashcroft SJH Aschcroft, Biochim Biophys Acta 1992 1175 45 59 10.1016/0167-4889(92)90008-Y 1482696
26. Difference in mechanism between glyceraldehyde- and glucose-induced insulin secretion from isolated rat pancreatic islets. S Taniguchi M Okinaka K Tanigawa I Miwa, J Biochem 2000 127 289 295 10731696 (Pubitemid 30136912)
27. Pancreatic islet glucose metabolism and regulation of insulin secretion. MD Meglasson FM Matschinsky, Diabetes Metab Rev 1986 2 163 214 10.1002/dmr.5610020301 2943567 (Pubitemid 16009507)
28. Distinguishing features of leucine and -ketoisocaproate sensing in pancreatic -cells. Z Gao RA Young G Li H Najafi C Buettger SS Sukumvanich RK Wong BA Wolf FM Matschinsky, Endocrinology 2003 144 1949 1957 10.1210/en.2002-0072 12697702 (Pubitemid 36543334)
29. Insulinotropic action of methyl pyruvate: enzyme and metabolic aspects. H Jijakli AB Nadi L Cook L Best A Sener WJ Malaisse, Arch Biochem Biophys 1996 335 245 257 10.1006/abbi.1996.0505 8914921 (Pubitemid 26384790)
30. Mechanism of the insulin-releasing action of -ketoisocaproate and related -keto acid anions. H Heissig KA Urban K Hastedt BJ Zünkler U Panten, Mol Pharmacol 2005 68 1097 1105 10.1124/mol.105.015388 16014804 (Pubitemid 41345801)
31. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. K Eto Y Tsubamoto Y Terauchi T Sugiyama T Kishimoto N Takahashi N Yamauchi N Kubota S Murayama T Aizawa Y Akanuma S Aizawa H Kasai Y Yazaki T Kaowaki, Science 1999 283 981 985 10.1126/science.283.5404.981 9974390
32. Identification of arginine as a precursor of endothelium-derived relaxing factor. I Sakuma DJ Stuehr SS Gross C Nathan R Levi, Proc Natl Acad Sci USA 1988 85 8644 8667 10.1073/pnas.85.22.8664 (Pubitemid 19025017)
33. The use of aminoguanidine, a selective iNOS inhibitor, to evaluate the role of nitric oxide in the development of autoimmune diabetes. JA Corbett MI McDaniel, Methods 1996 10 21 30 10.1006/meth.1996.0074 8812641 (Pubitemid 26293765)
34. Insulinotropic action of glucagon-like peptide-1-(7-37) in diabetic and nondiabetic subjects. DM Nathan E Schreiber H Fogel S Mojsov JF Habener, Diabetes Care 1992 15 270 276 10.2337/diacare.15.2.270 1547685
35. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. JC Henquin HP Meissner, Endocrinology 1984 115 1125 1134 10.1210/endo-115-3-1125 6086286 (Pubitemid 14074485)
36. The role of cyclic AMP in insulin release. WJ Malaisse F Malaisse-Lagae, Experientia 1984 40 1068 1075 10.1007/BF01971453 6092126 (Pubitemid 15147093)
37. 2+ in the electrically excitable pancreatic -cell. P Gilon M Nenquin JC Henquin, Biochem J 1995 311 259 267 7575463
38. Mechanism of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. SF Yan R Ramasamy AM Schmidt, Nature Clin Pract Endocrinol Metab 2008 4 285 293 10.1038/ncpendmet0786 (Pubitemid 351571138)